BamSEC and AlphaSense Join Forces
Learn More

Opko Health Inc.

NASDAQ: OPK    
Share price (12/20/24): $1.54    
Market cap (12/20/24): $1.051 billion
Search in Documents
Key Exhibits
External Links

Credit Agreements Filter

EX-10.1
from 10-Q 182 pages Waiver Under and Amendment No. 2 to Amended and Restated Credit Agreement
12/34/56
EX-10.1
from 8-K 17 pages Waiver Under and Amendment No. 1 to Amended and Restated Credit Agreement
12/34/56
EX-10.1
from 8-K 172 pages Amended and Restated Credit Agreement Dated as of August 30, 2021, Among Bio-Reference Laboratories, Inc., as the Company, the Subsidiaries From Time to Time Party Hereto as Subsidiary Borrowers, the Other Loan Parties Party Hereto, the Lenders Party Hereto, and Jpmorgan Chase Bank, N.A., as Administrative Agent Jpmorgan Chase Bank, N.A., as Sole Bookrunner and Sole Lead Arranger
12/34/56
EX-10.1
from 8-K 7 pages Amendment No. 12 to Credit Agreement
12/34/56
EX-10.38
from 10-K ~10 pages Opko Health, Inc. Credit Agreement February 25, 2020 Opko Health, Inc. Credit Agreement
12/34/56
EX-10.37
from 10-K 6 pages Amendment No. 11 to Credit Agreement
12/34/56
EX-10.36
from 10-K 10 pages Amendment No. 10 to Credit Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Amendment No. 9 to Credit Agreement
12/34/56
EX-10.1
from 10-Q 5 pages Amendment No. 8 to Credit Agreement
12/34/56
EX-10.32
from 10-K 17 pages Opko Health, Inc. Credit Agreement November 8, 2018 Opko Health, Inc. Credit Agreement
12/34/56
EX-10.1
from 10-Q 8 pages Waiver Under and Amendment No. 7 to Credit Agreement
12/34/56
EX-10.28
from 10-K 6 pages Amendment No. 6 to Credit Agreement
12/34/56
EX-10.27
from 10-K 10 pages Amendment No. 5 to Credit Agreement
12/34/56
EX-10.1
from 10-Q 6 pages Amendment No. 4 to Credit Agreement
12/34/56
EX-10.2
from 8-K 6 pages Amendment No. 3 to Credit Agreement
12/34/56
EX-10.23
from 10-K 135 pages Credit Agreement Dated as of November 5, 2015, Among Bio-Reference Laboratories, Inc., as the Company, the Subsidiaries From Time to Time Party Hereto as Subsidiary Borrowers, the Other Loan Parties Party Hereto, the Lenders Party Hereto, and Jpmorgan Chase Bank, N.A., as Administrative Agent J.P. Morgan Securities LLC, as Sole Bookrunner and Sole Lead Arranger
12/34/56
EX-10.1
from 10-Q 2 pages Amendment No. 2 to Credit Agreement
12/34/56
EX-10.3
from 8-K 46 pages By and Among Horizon Technology Funding Company LLC, a Delaware Limited Liability Company 76 Batterson Park Road Farmington, Ct 06032 as Lender and Acuity Pharmaceuticals, LLC F/K/a E-Acquisition Company II-B, LLC, a Delaware Limited Liability Company, Successor by Merger to Acuity Pharmaceuticals, Inc. 3701 Market Street Philadelphia, Pa 19104 and Exegenics, Inc., a Delaware Corporation 1250 Pittsford-Victor Road Pittsford, Ny 14534 Collectively, as Borrower Commitment Amount: $4,000,000
12/34/56
EX-10.2
from 8-K 24 pages Credit Agreement
12/34/56